Delivery Order SPE2DB22D3301-SPE2DB25FX5HY

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,488.37 firm fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets, with a period of performance through March 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,842.64 firm-fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets. The contract has an ultimate completion date of November 24, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,574.80 firm-fixed-price delivery order is for the supply of 60 tablets of the drug Everolimus 1 mg. The contract has a period of performance through December 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Everolimus 7.5 mg tablets. The contract, valued at $6,788.55, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The award, which has a completion date of December 13, 2024, is structured as a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,363.03 firm-fixed-price delivery order is for the supply of 4566998338 Everolimus 0.5 mg tablets, a pharmaceutical product used in various medical treatments. The contract has a completion date of January 22, 2025 and was awarded on January 21, 2025. No set-aside designation was used for this contract....
This federal contract award, valued at $37,530.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract covers the delivery of Everolimus 5 mg tablets, a medication used in various medical treatments. This award does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.83 firm fixed-price delivery order is for the supply of Everolimus 0.75 mg tablets, with a completion date of February 13, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award, valued at $6,391.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Everolimus 7.5 mg tablets to the Defense Logistics Agency (DLA). The $2,262.85 fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a completion date of November 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,169.56 firm fixed-price delivery order is for the supply of Everolimus 10 mg tablets to support military healthcare programs. The award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5HY
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX5HY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,831.23 delivery order is for the supply of 4566407539 Everolimus 0.75 mg tablets. This order is part of a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in pharmaceutical distribution and healthcare solutions make it a key vendor for federal government agencies, particularly within the military and veterans' healthcare systems.

Generated 5/20/25, 1:56 PM